← Back to list
MA05.003h, Speech and Non-Speech Generating Devices
Act
by Nov 17, 2025
Effective date
Nov 17, 2025
Identified
Jun 19, 2026
Summary
Independence Blue Cross simplified MA05.003h by removing detailed language about severe speech impairment definitions and device usage to align with CMS Medicare standards. The core coverage criteria for speech-generating devices remain unchanged, but billing teams should verify that SLP evaluations now strictly follow CMS/Medicare guidelines rather than company-specific definitions.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.
What to do
by Nov 17, 2025 · 5 steps
01Billing team must review and update internal documentation standards to align SLP evaluation requirements with CMS Medicare guidelines rather than company-specific definitions.
02Audit current SGD claims in process to ensure SLP evaluations meet the revised policy criteria (medical condition causing severe expressive speech impairment, documented functional abilities, communication goals, device rationale, training plan, and functional benefit).
03Update billing system notes and training materials to reflect that only CMS-aligned definitions apply.
04Providers should be notified that SGD prior authorization submissions must now reference Medicare statutes, regulations, NCDs, and LCDs.
05No claim denials are anticipated for compliant submissions, but claims lacking updated SLP documentation aligned to CMS standards may face delays.
Codes mentioned
E2500E2502E2504E2506
Original notice
MA05.003h, Speech and Non-Speech Generating Devices
medpolicy.ibx.com · Always check the source before changing claims.